Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
The addition of Erleada to ADT might present much less profit in sufferers with metastatic castration-sensitive prostate most cancers and fewer bone metastases:...
For sufferers dwelling with myeloproliferative neoplasms (MPNs), constructing lasting relationships with the care staff can carry energy, consolation and readability throughout a difficult...
